Results     01-Jun-20
Analysis
Advanced Enzyme Technologies
Impact of pandemic may not be significant
Related Tables
 Advanced Enzymes Technologies: Results
Advanced Enzyme Technologies net sales remained flat at Rs 110.26 crore for quarter ended Mar20. The company operating margins decreased 80 bps to 44.2% leading 2% decrease in operating profits to Rs 48.7 crore.

Other income stood at Rs 1.84 crore compared to Rs 2.64 crore. Interest cost was Rs 69 lakh compared to Rs 58 lakh. Depreciation rose 26% to Rs 6.65 crore. PBT was down 7% to Rs 43.2 crore.

Tax expenses were down 19% to Rs 10.52 crore owing to which the company's net profit reported was down 2% to Rs 32.68 crore. Further considering minority interest, Bottomline of the company was down 3% to Rs 31.33 crore.

In March 2020, the World Health Organisation declared COVID-19 to be a pandemic and several restrictions have been imposed by the Governments across the globe on the travel, goods movement and transportation considering public health and safety measures. Considering the Company's/ Group's products are classified as an ‘essential commodity', management believes that the impact of the pandemic may not be significant. As of today, production facilities remain operational, following enhanced internal safety guidelines. Management has also considered the impact of COVID-19 on the business for the foreseeable future and have concluded that the company has sufficient resources to continue as a going concern.

Consolidated performance for the year ended Mar20

For year ended Mar20, net sales rose 6% to Rs 443.99 crore. The company operating margins increased 240 bps to 45.6%. As a result operating profits rose 11% to Rs 202.33 crore.

Other income rose 12% to Rs 5.64 crore. Interest cost was down 22% to Rs 3.04 crore. Depreciation rose 22% to Rs 25.78 crore. PBT was up 11% to Rs 179.16 crore.

The effective tax rate decreased to 25.7% from 28.4% owing to which the company's net profit rose 15% at Rs 133.05 crore. Further considering minority interest, Bottomline of the company fell 16% to Rs 129.29 crore.

The scrip is currently trading at Rs 151

Previous News
  Advanced Enzyme Techs. schedules AGM
 ( Corporate News - 26-Jun-24   13:49 )
  Advanced Enzyme Techs. announces board meeting date
 ( Corporate News - 08-Aug-23   19:29 )
  Advanced Enzyme updates on clinical trials for its health supplements
 ( Corporate News - 13-Sep-21   11:27 )
  Advanced Enzyme Technologies consolidated net profit rises 18.25% in the March 2019 quarter
 ( Results - Announcements 24-May-19   17:01 )
  Advanced Enzyme Technologies fixes record date for final dividend
 ( Market Beat - Reports 21-Jul-22   16:08 )
  Board of Advanced Enzyme Techs. recommends final dividend
 ( Corporate News - 31-May-21   12:28 )
  Advanced Enzyme Technologies Ltd Spurts 2.63%
 ( Hot Pursuit - 04-Jan-23   09:30 )
  Advanced Enzyme Technologies
 ( Results - Analysis 15-Feb-21   11:57 )
  Advanced Enzyme soars on positive breakthrough in RCTs of COVID-fatigue treating enzymes
 ( Hot Pursuit - 13-Sep-21   11:15 )
  Volumes soar at Advanced Enzyme Technologies Ltd counter
 ( Hot Pursuit - 24-Apr-18   14:30 )
  Advanced Enzyme Technologies
 ( Results - Analysis 31-May-21   10:38 )
Other Stories
  Apollo Hospitals Enterprise
  04-Jun-24   10:04
  ITL Industries
  01-Jun-24   02:14
  International Combustion (India)
  31-May-24   11:32
  Fluidomat
  31-May-24   11:28
  ISGEC Heavy Engineering
  31-May-24   11:24
  Sreeleathers
  31-May-24   11:20
  Cummins India
  31-May-24   11:18
  Bata India
  31-May-24   09:55
  Tata Steel
  31-May-24   08:36
  India Nippon Electricals
  31-May-24   07:03
Back Top